| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Creativity and Innovation Management :- Thought Leadership |
|
Main Subject - Creativity and Innovation Management :- Thought Leadership
Leadership is only sustainable when leaders consistently come up with good ideas – when they are de According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product pendable thought leaders. It follows then that leaders would be more effective if they knew how to ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in manage creativity and innovation. Some of the tools for effective creativity management include: lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a) Develop the brief. Formulating a brief helps i) induce the problem solving state of mind, ii) cr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe eates structures with boundaries and limitations within which experimentation can take place and ii d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ) enhances motivation. b) One tacit knowledge elicitation and lateral thinking technique is to use ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the five senses. This helps define problems and generate ideas along five different pathways, inst easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi antly increasing the quantity of ideas and further increasing the probability that quality ideas wi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ll be generated. c) Setting a clear goal. Goals and incremental targets produce more output than s and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ imply “do your best.” Prolific screenwriters that stick to goals produce more output and move along ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the learning curve much faster than those who simply wait for inspiration. Look at the untold numbe ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a r of people with unfinished manuscripts under their beds. d) Separate idea generation from idea va dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod luation. Creative and critical thinking and two separate and distinct activities. e) Persistence p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ays off. Persistence slowly but surely helps develop the competencies required for quality output. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Failure is a learning activity. Ridley Scott didn’t achieve financial success with Blade Runner but t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel went on to make some very successful movies. These and other topics are covered in depth in the MB ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust A dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products and Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from http://w . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ww.managing-creativity.com Kal Bishop, MBA ********************************** You are free to re elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip produce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Buy A Business And Make A Bundle Of Money Fast -- Simply By Avoiding These People Like The Plague Don't Be Fooled: Marketing Is Not About Meeting Customer Needs
|